PF TYLOSIN PREMIX 25% WW POWDER

Negara: Malaysia

Bahasa: Inggris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Beli Sekarang

Unduh Karakteristik produk (SPC)
25-01-2018

Bahan aktif:

TYLOSIN PHOSPHATE

Tersedia dari:

Panfast Marketing (m) Sdn Bhd

INN (Nama Internasional):

TYLOSIN PHOSPHATE

Unit dalam paket:

25 kg

Diproduksi oleh:

Shennong Animal Health (Malaysia) Sdn. Bhd.

Karakteristik produk

                                PF TYLOSIN PREMIX 25% W/W POWDER
[Type text]
DISTRIBUTED BY:
PANFAST MARKETING (M) SDN.BHD.
PENANG SCIENCE PARK 1102, MUKIM 13, LORONG PERINDUSTRIAN BUKIT
MINYAK 18, KAWASAN PERINDUSTRIAN BUKIT MINYAK,
14100 SIMPANG AMPAT, PENANG, MALAYSIA
TEL: +604-5016868 FAX: +604-5016866
MANUFACTURED BY:
SHENNONG ANIMAL HEALTH (M) SDN.BHD.
No.6, 8, 10, Jalan Industri USJ 1/19, Taman Perindustrian USJ 1
47610 SUBANG JAYA, Selangor Darul Ehsan, Malaysia.
Tel: 03-8011 4646
Fax : 03-8024 1166
COMPOSITION:
Tylosin (as Tylosin Phosphate)………………………..250mg
Exp.
Qs……………………………….………………..……………….1g
DESCRIPTION
White colour powder
PHARMACODYNAMIC
Tylosin
is
a
macrolide
antibiotic
produced
by
a
strain
of
_Streptomyces _
_fradiae_.
It
exerts
its
antimicrobial
effect
by
inhibiting protein synthesis of susceptible micro-organisms.
The tylosin spectrum of activity includes Gram-positive bacteria,
some Gram-negative strains such as _Pasteurella_, and _Mycoplasma _
spps at concentrations of 16µg/ml or less.
PHARMACOKINETIC
Absorption: Tylosin reaches maximal blood levels between 1 and
3 hours after an oral dose. Minimal or no blood levels remain 24
hours after an oral dose.
Distribution: After oral doses were given to pigs, tylosin was
found in all tissues, between 30 minutes and two hours after
administration, except for the brain and spinal cord.
Biotransformation and Elimination: It has been shown that most
of the material which is excreted is to be found in the faeces and
consists
of
tylosin
(factor
A),
relomycin
(factor
D)
and
dihydrodesmycosin.
INDICATION
Pigs:
For the prevention and control of enzootic pneumonia.
For the treatment and control of _ Lawsonia intracellularis_, the
organism associated with Porcine Intestinal Adenomatosis (Ileitis)
and Porcine Haemorrhagic Enteropathy.
ROUTE OF ADMINISTRATION
Oral
RECOMMENDED DOSE
For incorporation into dry feed at the registered mill.
A manufacturer who is approved to incorporate directly at any
concentration,
veterinary
medicin
                                
                                Baca dokumen lengkapnya
                                
                            

Peringatan pencarian terkait dengan produk ini